
Sun Pharma Acquires Checkpoint Therapeutics for $355 Million
- Sun Pharmaceutical Industries Ltd announced the acquisition of Checkpoint Therapeutics, Inc., a Nasdaq-listed company specializing in immunotherapy and targeted oncology.
- Checkpoint Therapeutics has FDA approval for UNLOXCYT (cosibel...